Focuses on biotechnology companies, translating scientific innovations into therapies across early‑stage startups to public companies.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
United States
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
United States of America
54.5%United Kingdom
22.7%Canada
9.1%Australia
4.5%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
No stages listed
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
MPM BioVentures 2022
Vintage 2022 • $351M
Oncology Impact Fund II
Vintage 2021 • $650M
MPM BioVentures Fund I
$230M
MPM BioVentures Fund II
$600M
MPM BioVentures Fund (Tracxn)
$79.9M